Showing 821 - 840 results of 1,825 for search '"bowel"', query time: 0.06s Refine Results
  1. 821
  2. 822
  3. 823
  4. 824
  5. 825
  6. 826
  7. 827
  8. 828
  9. 829
  10. 830
  11. 831
  12. 832

    Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome by Wenhua Tao, Xiaoyun Dong, Guimei Kong, Penghua Fang, Xiaoli Huang, Ping Bo

    Published 2016-01-01
    “…Although the differential expression of microRNA (miRNA) genes has been identified in many diseases, little information exists concerning the miRNA expression profile in type 2 diabetes mellitus (T2DM) with diarrhea-predominant irritable bowel syndrome (D-IBS). Therefore, the specific expression of miRNAs in diabetes with D-IBS is identified in the study. …”
    Get full text
    Article
  13. 833
  14. 834
  15. 835
  16. 836
  17. 837
  18. 838
  19. 839
  20. 840

    Secukinumab-Induced Inflammatory Bowel Disease in a Patient Treated for Chronic Plaque Psoriasis and Psoriatic Arthritis: A Case Report and Review of the Role of Novel Biologic Agents Targeting the p19 Subunit of IL-23 by K. M. Darch, T. L. Holland, L. J. Spelman

    Published 2020-01-01
    “…It was determined by the gastroenterologist that this may represent secukinumab-induced inflammatory bowel disease. We will review the current understanding of the role of IL-17 in inflammatory bowel disease and the important role of novel agents that target the p19 subunit of IL-23 which have shown significant promise in the management of not only chronic plaque psoriasis and psoriatic arthritis, but also inflammatory bowel disease itself.…”
    Get full text
    Article